Evidence map›Paper›PMID 30474191›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2019

Utility of HbA

D Bhattacharjee, S Vracar, R A Round, P G Nightingale, J A Williams, G V Gkoutos, I M Stratton, R Parker, S D Luzio, J Webber and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Utility of HbADiabetic medicine : a journal of the British Diabetic Association · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

D BhattacharjeeMedical School, University of Birmingham, Birmingham, UK.
S VracarMedical School, University of Birmingham, Birmingham, UK.
R A RoundClinical Laboratory Services, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
P G NightingaleInstitute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
J A WilliamsInstitute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
G V GkoutosInstitute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
I M StrattonGloucestershire Retinal Research Group, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK.
R ParkerLeeds Liver Unit, St James's University Hospital, Leeds, UK.
S D LuzioDiabetes Translational Research Group, Diabetes Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
J WebberDiabetes Translational Research Group, Diabetes Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
S E ManleyDiabetes Translational Research Group, Diabetes Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.ORCID 0000-0002-8298-4511
G A RobertsDiabetes Translational Research Group, Diabetes Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
S GhoshDiabetes Translational Research Group, Diabetes Centre, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
University Hospitals Birmingham NHS Foundation Trust · GBUniversity of Birmingham · GBGloucestershire Hospitals NHS Foundation Trust · GBSt James's University Hospital · GB

Funding

Mouse Phenotyping Informatics Infrastructure - MP12UM1HG006370 · NHGRI · EUROPEAN MOLECULAR BIOLOGY LABORATORY · PI Pilar Cacheiro Martinez, Helen Elizabeth Parkinson · 2016 to 2026
$20.4M
Medical Research Council G1100448NHGRI NIH HHS UM1 HG006370NHGRI NIH HHS UM1HG006370
6 · The paper itself

Abstract

aimsTo investigate the relationship between HbA

methodsHbA

resultsThe median (interquartile range) age of the diabetes with cirrhosis group was 55 (49-63) years compared to 60 (50-71) years (P=0.13) in the group without cirrhosis. In the diabetes with cirrhosis group there were 21 men (72%) compared with 86 men (69%) in the group with diabetes and no cirrhosis (P=0.82). Of the group with diabetes and cirrhosis, 27 people (93%) were of white European ethnicity, two (7%) were South Asian and none was of Afro-Caribbean/other ethnicity compared with 94 (75%), 16 (13%), 10 (8%)/5 (4%), respectively, in the group with diabetes and no cirrhosis (P=0.20). Median (interquartile range) HbA

conclusionHbA

Indexed as

Liver TransplantationAgedBlood GlucoseDiabetic NephropathiesDisease ManagementErythrocyte CountErythrocytes, AbnormalFemaleGlycated HemoglobinHumansLiver CirrhosisMaleMiddle AgedPredictive Value of TestsBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID30474191
PMCPMC6850030
OpenAlexW2902200212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.